Chemerin, an adipokine, has been reported to reduce the production of pro-inflammatory cytokines and neutrophil infiltration. This study investigated the role of Chemerin and its natural receptor, ChemR23, as well as its downstream mediator calmodulin-dependent protein kinase kinase 2 (CAMKK2)/adenosine monophosphate-activated protein kinase (AMPK) /Nuclear factor erythroid 2-related factor 2 (Nrf2) following germinal matrix hemorrhage (GMH) in neonatal rats, with a specific focus on inflammation. GMH was induced by intraparenchymal injection of bacterial collagenase (0.3U) in P7 rat pups. The results demonstrated that human recombinant Chemerin (rh-Chemerin) improved neurological and morphological outcomes after GMH. Rh-Chemerin promoted accumulation and proliferation of M2 microglia in periventricular regions at 72 h. Rh-Chemerin increased phosphorylation of CAMKK2, AMPK and expression of Nrf2, and decreased IL-1beta, IL-6 and TNF-alpha levels. Selective inhibition of ChemR23/ CAMKK2/AMPK signaling in microglia via intracerebroventricular delivery of liposome-encapsulated specific ChemR23 (Lipo-alpha-NETA), CAMKK2 (Lipo-STO-609) and AMPK (Lipo-Dorsomorphin) inhibitor increased the expression levels of IL-1beta, IL-6 and TNF-alpha, demonstrating that ChemR23/CAMKK2/ AMPK signaling in microglia suppressed inflammatory response after GMH. Cumulatively, these data showed that rh-Chemerin ameliorated GMH-induced inflammatory response by promoting ChemR23/ CAMKK2/AMPK/Nrf2 pathway, and M2 microglia may be a major mediator of this effect. Thus, rhChemerin can serve as a potential agent to reduce the inflammatory response following GMH.
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Introduction
Germinal matrix hemorrhage (GMH) is a common cerebrovascular event that affects up to 20% of premature infants, and leads to severe long-term neurological and cognitive deficits, including cerebral palsy and mental retardation (Ballabh, 2014) . After the hemorrhage occurs, the damage of brain tissue is amplified by the activation of inflammatory cascades, which are responsible for the further neurodegeneration (Brown and Neher, 2010; Chen et al., 2015; Tao et al., 2016; Zhou et al., 2014) . Given the extended inflammation-induced tissue destruction, the suppression of inflammatory response could be a particularly important intervention to limit GMH-induced brain injury.
Microglia play critical roles in the immune response after GMH (Aronowski and Zhao, 2011). Traditionally, microglia was considered injurious in the past-hemorrhagic brain due to the production of inflammatory cytokines (Lan et al., 2017) . However, emerging data show that microglia have a beneficial role in neonatal stroke and that depletion of microglia exacerbates neuroinflammation and brain injury in neonatal ischemic stroke (Chip et al., 2017; Fernandez-Lopez et al., 2016) . Furthermore, preclinical studies show that regulation of the immune response after GMH involves an M1 to M2 phenotype transformation in microglia, and that promoting M2 polarization inhibits the expression of proinflammatory cytokines (Tao et al., 2016; Xu et al., 2015) .
